280 related articles for article (PubMed ID: 33195396)
21. Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer.
Fernandes PH; Saam J; Peterson J; Hughes E; Kaldate R; Cummings S; Theisen A; Chen S; Trost J; Roa BB
Cancer; 2014 Apr; 120(7):963-7. PubMed ID: 24415441
[TBL] [Abstract][Full Text] [Related]
22. DNA Repair Function Scores for 2172 Variants in the BRCA1 Amino-Terminus.
Diabate M; Islam MM; Nagy G; Banerjee T; Dhar S; Smith N; Adamovich AI; Starita LM; Parvin JD
bioRxiv; 2023 Apr; ():. PubMed ID: 37090572
[TBL] [Abstract][Full Text] [Related]
23. Antiparallel Coiled-Coil Interactions Mediate the Homodimerization of the DNA Damage-Repair Protein PALB2.
Song F; Li M; Liu G; Swapna GVT; Daigham NS; Xia B; Montelione GT; Bunting SF
Biochemistry; 2018 Nov; 57(47):6581-6591. PubMed ID: 30289697
[TBL] [Abstract][Full Text] [Related]
24. Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.
Surowy HM; Sutter C; Mittnacht M; Klaes R; Schaefer D; Evers C; Burgemeister AL; Goehringer C; Dikow N; Heil J; Golatta M; Schott S; Schneeweiss A; Bugert P; Sohn C; Bartram CR; Burwinkel B
Breast Cancer Res Treat; 2014 Jun; 145(2):451-60. PubMed ID: 24728577
[TBL] [Abstract][Full Text] [Related]
25. Analysis of PALB2 in a cohort of Italian breast cancer patients: identification of a novel PALB2 truncating mutation.
Vietri MT; Caliendo G; Schiano C; Casamassimi A; Molinari AM; Napoli C; Cioffi M
Fam Cancer; 2015 Sep; 14(3):341-8. PubMed ID: 25666743
[TBL] [Abstract][Full Text] [Related]
26. Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients.
Rodríguez-Balada M; Roig B; Melé M; Albacar C; Serrano S; Salvat M; Querol M; Borràs J; Martorell L; Gumà J
Clin Biochem; 2020 Feb; 76():17-23. PubMed ID: 31786208
[TBL] [Abstract][Full Text] [Related]
27. Splicing Analysis of 16
Valenzuela-Palomo A; Sanoguera-Miralles L; Bueno-Martínez E; Esteban-Sánchez A; Llinares-Burguet I; García-Álvarez A; Pérez-Segura P; Gómez-Barrero S; de la Hoya M; Velasco-Sampedro EA
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139699
[TBL] [Abstract][Full Text] [Related]
28. Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.
Santos C; Peixoto A; Rocha P; Pinto P; Bizarro S; Pinheiro M; Pinto C; Henrique R; Teixeira MR
J Mol Diagn; 2014 May; 16(3):324-34. PubMed ID: 24607278
[TBL] [Abstract][Full Text] [Related]
29. Alternative splicing and ACMG-AMP-2015-based classification of PALB2 genetic variants: an ENIGMA report.
Lopez-Perolio I; Leman R; Behar R; Lattimore V; Pearson JF; Castéra L; Martins A; Vaur D; Goardon N; Davy G; Garre P; García-Barberán V; Llovet P; Pérez-Segura P; Díaz-Rubio E; Caldés T; Hruska KS; Hsuan V; Wu S; Pesaran T; Karam R; Vallon-Christersson J; Borg A; ; Valenzuela-Palomo A; Velasco EA; Southey M; Vreeswijk MPG; Devilee P; Kvist A; Spurdle AB; Walker LC; Krieger S; de la Hoya M
J Med Genet; 2019 Jul; 56(7):453-460. PubMed ID: 30890586
[TBL] [Abstract][Full Text] [Related]
30. Structure analysis of deleterious nsSNPs in human PALB2 protein for functional inference.
Nawar N; Paul A; Mahmood HN; Faisal MI; Hosen MI; Shekhar HU
Bioinformation; 2021; 17(3):424-438. PubMed ID: 34092963
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data.
van Marcke C; Collard A; Vikkula M; Duhoux FP
Crit Rev Oncol Hematol; 2018 Dec; 132():138-144. PubMed ID: 30447919
[TBL] [Abstract][Full Text] [Related]
32. Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA.
Quiles F; Menéndez M; Tornero E; del Valle J; Teulé À; Palanca S; Izquierdo A; Gómez C; Campos O; Santamaria R; Brunet J; Capellá G; Feliubadaló L; Lázaro C
Breast Cancer Res Treat; 2016 Jan; 155(2):253-60. PubMed ID: 26780556
[TBL] [Abstract][Full Text] [Related]
33. Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of
Gelli E; Colombo M; Pinto AM; De Vecchi G; Foglia C; Amitrano S; Morbidoni V; Imperatore V; Manoukian S; Baldassarri M; Lo Rizzo C; Catania L; Frullanti E; Tagliafico E; Cortesi L; Spaggiari F; Mencarelli MA; Trevisson E; Radice P; Renieri A; Ariani F
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30832263
[TBL] [Abstract][Full Text] [Related]
34. Mis-splicing in breast cancer: identification of pathogenic BRCA2 variants by systematic minigene assays.
Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Goina E; Acedo A; Buratti E; Velasco EA
J Pathol; 2019 Aug; 248(4):409-420. PubMed ID: 30883759
[TBL] [Abstract][Full Text] [Related]
35. Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance.
Woods NT; Baskin R; Golubeva V; Jhuraney A; De-Gregoriis G; Vaclova T; Goldgar DE; Couch FJ; Carvalho MA; Iversen ES; Monteiro AN
NPJ Genom Med; 2016; 1():16001-. PubMed ID: 28781887
[TBL] [Abstract][Full Text] [Related]
36. Spectrum and management of breast cancer patients with variant of uncertain significance mutations at a tertiary care centre in North India.
Mittal A; Deo SVS; Gogia A; Batra A; Kumar A; Bhoriwal S; Deb KS; Dhamija E; Ramprasad VL; Olopade O; Pramanik R
Ecancermedicalscience; 2022; 16():1434. PubMed ID: 36200007
[TBL] [Abstract][Full Text] [Related]
37. Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management.
Wu S; Zhou J; Zhang K; Chen H; Luo M; Lu Y; Sun Y; Chen Y
Front Oncol; 2020; 10():301. PubMed ID: 32185139
[TBL] [Abstract][Full Text] [Related]
38. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
[TBL] [Abstract][Full Text] [Related]
39. Management of PALB2-associated breast cancer: A literature review and case report.
Toss A; Ponzoni O; Riccò B; Piombino C; Moscetti L; Combi F; Palma E; Papi S; Tenedini E; Tazzioli G; Dominici M; Cortesi L
Clin Case Rep; 2023 Aug; 11(8):e7747. PubMed ID: 37621724
[TBL] [Abstract][Full Text] [Related]
40. A PALB2-interacting domain in RNF168 couples homologous recombination to DNA break-induced chromatin ubiquitylation.
Luijsterburg MS; Typas D; Caron MC; Wiegant WW; van den Heuvel D; Boonen RA; Couturier AM; Mullenders LH; Masson JY; van Attikum H
Elife; 2017 Feb; 6():. PubMed ID: 28240985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
